Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
1 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapy Drug Discovery Outsourcing
1.2 Classification of Cancer Immunotherapy Drug Discovery Outsourcing by Types
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Comparison by Types (2020-2025)
1.2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Immunomodulators
1.2.5 Oncolytic Viral Therapies and Cancer Vaccines
1.2.6 Other
1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Regions
1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2015-2025)
1.5 Global Market Size of Cancer Immunotherapy Drug Discovery Outsourcing (2015-2025)
2 Manufacturers Profiles
2.1 Aquila BioMedical
2.1.1 Business Overview
2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.2 BPS Bioscience, Inc.
2.2.1 Business Overview
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.3 Celentyx Ltd
2.3.1 Business Overview
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.4 Crown Bioscience, Inc.
2.4.1 Business Overview
2.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.5 DiscoverX Corporation
2.5.1 Business Overview
2.5.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.6 Explicyte
2.6.1 Business Overview
2.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.7 Genscript Biotech Corporation
2.7.1 Business Overview
2.7.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.8 HD Biosciences Co.
2.8.1 Business Overview
2.8.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.9 Horizon Discovery Group PLC
2.9.1 Business Overview
2.9.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.10 ImmunXperts SA
2.10.1 Business Overview
2.10.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.11 Molecular Imaging, Inc.
2.11.1 Business Overview
2.11.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.12 Promega Corporation,Personalis, Inc.
2.12.1 Business Overview
2.12.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
2.13 STC Biologics
2.13.1 Business Overview
2.13.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competition, by Players
3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
3.2.2 Top 10 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
3.3 Market Competition Trend
4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Regions
4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
4.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
4.5 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
5 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
5.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2015-2019)
5.2 USA Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
5.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
5.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
6 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2015-2019)
6.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
6.3 UK Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
6.4 France Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
6.5 Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
6.6 Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
7.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2015-2019)
7.2 China Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
7.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
7.4 Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
7.5 India Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
8 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries
8.1 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2015-2019)
8.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
8.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
8.4 Colombia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Cancer Immunotherapy Drug Discovery Outsourcing by Countries
9.1 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2015-2019)
9.2 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
9.3 UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
9.4 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
9.5 Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
9.6 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2015-2019)
10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Type
10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Type (2015-2019)
10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Type (2020-2025)
10.3 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.4 Immunomodulators Revenue Growth Rate (2015-2025)
10.5 Oncolytic Viral Therapies and Cancer Vaccines Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Application
11.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2015-2019)
11.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Application (2020-2025)
11.3 Lung Revenue Growth (2015-2019)
11.4 Breast Revenue Growth (2015-2019)
11.5 Colorectal Revenue Growth (2015-2019)
11.6 Melanoma Revenue Growth (2015-2019)
11.7 Prostate Revenue Growth (2015-2019)
11.8 Head and Neck Revenue Growth (2015-2019)
11.9 Ovarian Revenue Growth (2015-2019)
11.10 Pancreatic Revenue Growth (2015-2019)
12 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2020-2025)
12.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2020-2025)
12.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Regions (2020-2025)
12.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2020-2025)
12.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2020-2025)
12.6 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
